The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Zika Virus-Global Market Insights and Sales Trends 2025
Synopsis
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
The global Zika Virus market size is expected to reach US$ 144 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Zika Virus in various end use industries. The expanding demands from the Diagnostic Centers, Hospitals and Pathology Labs,, are propelling Zika Virus market. Molecular Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Serologic Test segment is estimated at % CAGR for the next seven-year period.
Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zika Virus, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zika Virus market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zika Virus market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zika Virus sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zika Virus covered in this report include Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, NewLink Genetics, Immunovaccine and GlaxoSmithKline, etc.
The global Zika Virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Global Zika Virus market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zika Virus market, Segment by Type:
Molecular Test
Serologic Test
Global Zika Virus market, by Application
Diagnostic Centers
Hospitals
Pathology Labs
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zika Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
The global Zika Virus market size is expected to reach US$ 144 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Zika Virus in various end use industries. The expanding demands from the Diagnostic Centers, Hospitals and Pathology Labs,, are propelling Zika Virus market. Molecular Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Serologic Test segment is estimated at % CAGR for the next seven-year period.
Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zika Virus, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zika Virus market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zika Virus market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zika Virus sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zika Virus covered in this report include Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, NewLink Genetics, Immunovaccine and GlaxoSmithKline, etc.
The global Zika Virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Global Zika Virus market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zika Virus market, Segment by Type:
Molecular Test
Serologic Test
Global Zika Virus market, by Application
Diagnostic Centers
Hospitals
Pathology Labs
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zika Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Zika Virus Market Overview
1.1 Zika Virus Product Overview
1.2 Zika Virus Market Segment by Type
1.2.1 Molecular Test
1.2.2 Serologic Test
1.3 Global Zika Virus Market Size by Type
1.3.1 Global Zika Virus Market Size Overview by Type (2018-2029)
1.3.2 Global Zika Virus Historic Market Size Review by Type (2018-2023)
1.3.3 Global Zika Virus Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Zika Virus Sales Breakdown by Type (2018-2023)
1.4.2 Europe Zika Virus Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Zika Virus Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Zika Virus Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Zika Virus Sales Breakdown by Type (2018-2023)
2 Global Zika Virus Market Competition by Company
2.1 Global Top Players by Zika Virus Sales (2018-2023)
2.2 Global Top Players by Zika Virus Revenue (2018-2023)
2.3 Global Top Players by Zika Virus Price (2018-2023)
2.4 Global Top Manufacturers Zika Virus Manufacturing Base Distribution, Sales Area, Product Type
2.5 Zika Virus Market Competitive Situation and Trends
2.5.1 Zika Virus Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Zika Virus Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zika Virus as of 2022)
2.7 Date of Key Manufacturers Enter into Zika Virus Market
2.8 Key Manufacturers Zika Virus Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Zika Virus Status and Outlook by Region
3.1 Global Zika Virus Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Zika Virus Historic Market Size by Region
3.2.1 Global Zika Virus Sales in Volume by Region (2018-2023)
3.2.2 Global Zika Virus Sales in Value by Region (2018-2023)
3.2.3 Global Zika Virus Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Zika Virus Forecasted Market Size by Region
3.3.1 Global Zika Virus Sales in Volume by Region (2024-2029)
3.3.2 Global Zika Virus Sales in Value by Region (2024-2029)
3.3.3 Global Zika Virus Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Zika Virus by Application
4.1 Zika Virus Market Segment by Application
4.1.1 Diagnostic Centers
4.1.2 Hospitals
4.1.3 Pathology Labs
4.2 Global Zika Virus Market Size by Application
4.2.1 Global Zika Virus Market Size Overview by Application (2018-2029)
4.2.2 Global Zika Virus Historic Market Size Review by Application (2018-2023)
4.2.3 Global Zika Virus Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Zika Virus Sales Breakdown by Application (2018-2023)
4.3.2 Europe Zika Virus Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Zika Virus Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Zika Virus Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Zika Virus Sales Breakdown by Application (2018-2023)
5 North America Zika Virus by Country
5.1 North America Zika Virus Historic Market Size by Country
5.1.1 North America Zika Virus Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Zika Virus Sales in Volume by Country (2018-2023)
5.1.3 North America Zika Virus Sales in Value by Country (2018-2023)
5.2 North America Zika Virus Forecasted Market Size by Country
5.2.1 North America Zika Virus Sales in Volume by Country (2024-2029)
5.2.2 North America Zika Virus Sales in Value by Country (2024-2029)
6 Europe Zika Virus by Country
6.1 Europe Zika Virus Historic Market Size by Country
6.1.1 Europe Zika Virus Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Zika Virus Sales in Volume by Country (2018-2023)
6.1.3 Europe Zika Virus Sales in Value by Country (2018-2023)
6.2 Europe Zika Virus Forecasted Market Size by Country
6.2.1 Europe Zika Virus Sales in Volume by Country (2024-2029)
6.2.2 Europe Zika Virus Sales in Value by Country (2024-2029)
7 Asia-Pacific Zika Virus by Region
7.1 Asia-Pacific Zika Virus Historic Market Size by Region
7.1.1 Asia-Pacific Zika Virus Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Zika Virus Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Zika Virus Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Zika Virus Forecasted Market Size by Region
7.2.1 Asia-Pacific Zika Virus Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Zika Virus Sales in Value by Region (2024-2029)
8 Latin America Zika Virus by Country
8.1 Latin America Zika Virus Historic Market Size by Country
8.1.1 Latin America Zika Virus Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Zika Virus Sales in Volume by Country (2018-2023)
8.1.3 Latin America Zika Virus Sales in Value by Country (2018-2023)
8.2 Latin America Zika Virus Forecasted Market Size by Country
8.2.1 Latin America Zika Virus Sales in Volume by Country (2024-2029)
8.2.2 Latin America Zika Virus Sales in Value by Country (2024-2029)
9 Middle East and Africa Zika Virus by Country
9.1 Middle East and Africa Zika Virus Historic Market Size by Country
9.1.1 Middle East and Africa Zika Virus Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Zika Virus Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Zika Virus Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Zika Virus Forecasted Market Size by Country
9.2.1 Middle East and Africa Zika Virus Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Zika Virus Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bharat Biotech Zika Virus Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Inovio Pharmaceuticals and GeneOne Life Sciences
10.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Company Information
10.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Introduction and Business Overview
10.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Products Offered
10.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Development
10.3 Intrexon
10.3.1 Intrexon Company Information
10.3.2 Intrexon Introduction and Business Overview
10.3.3 Intrexon Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Intrexon Zika Virus Products Offered
10.3.5 Intrexon Recent Development
10.4 Cerus
10.4.1 Cerus Company Information
10.4.2 Cerus Introduction and Business Overview
10.4.3 Cerus Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cerus Zika Virus Products Offered
10.4.5 Cerus Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Zika Virus Products Offered
10.5.5 Sanofi Recent Development
10.6 NewLink Genetics
10.6.1 NewLink Genetics Company Information
10.6.2 NewLink Genetics Introduction and Business Overview
10.6.3 NewLink Genetics Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.6.4 NewLink Genetics Zika Virus Products Offered
10.6.5 NewLink Genetics Recent Development
10.7 Immunovaccine
10.7.1 Immunovaccine Company Information
10.7.2 Immunovaccine Introduction and Business Overview
10.7.3 Immunovaccine Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Immunovaccine Zika Virus Products Offered
10.7.5 Immunovaccine Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline Zika Virus Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GlaxoSmithKline Zika Virus Products Offered
10.8.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Zika Virus Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Zika Virus Industrial Chain Analysis
11.4 Zika Virus Market Dynamics
11.4.1 Zika Virus Industry Trends
11.4.2 Zika Virus Market Drivers
11.4.3 Zika Virus Market Challenges
11.4.4 Zika Virus Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Zika Virus Distributors
12.3 Zika Virus Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
